Goal 3: Advance Translational Research

NHLBI Cardiovascular Engineering Strategy

Most impressive and impactful advances in CV diagnostics and therapies came in the last 50 years from CV engineering, including implantable devices and imaging technology. CV engineers are developing next breakthrough technology including tissue engineering and flexible electronics. However, organizational structure of NIH does not have an entity responsible for strategic development of CV engineering. NIBIB does not support cardiovascular field due to historically defined portfolio excluding CV engineering. NHLBI does not have a review group or study section responsible for CV Engineering portfolio.

Tags (Keywords associated with the idea)


8 net votes
17 up votes
9 down votes
Idea No. 501